Core 1: Human Subjects Core with centralized data and sample handling
Official title: Core 1: Human Subjects Core
Funded at New York Blood Center · NIH-11365812 · Data updated 2026-11-12
A central unit at the New York Blood Center helps collect and manage high-quality patient samples and clinical data to support four research projects and shares clinical insights with lab scientists.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York Blood Center NIH-funded |
| Lab location | 1 site (Rye, UNITED STATES) |
| Project start | July 20, 2020 |
| Project end | June 30, 2030 |
| Funding year | 2026 |
| Award (this year) | $490,395 |
| NIH project number | 5P01HL149626-07 |
| Project ID | NIH-11365812 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals providing blood samples or clinical data related to hematology and transfusion medicine who consent to participate.
✕Less likely to help
Patients whose data or samples are not used or who do not consent may not directly benefit.
What this research studies
This grant funds a centralized Human Subjects Core that coordinates collection, storage, and tracking of human samples and related clinical information. It uses a cloud-based database and weekly cross-team meetings to ensure data quality and timely access for researchers. The core also provides clinical expertise to help interpret laboratory results in the context of blood-related conditions and transfusion medicine. By streamlining processes and aligning clinical data with lab analyses, the Core aims to improve the translational relevance of the four projects in the renewal application.
Why it matters
Potential benefit: If successful, patients could benefit from faster, more accurate research findings that translate into better diagnostics and therapies for blood disorders.
How similar studies have gone: Similar cores have shown improved data quality and faster integration of clinical information with laboratory findings in multi-project grants.
Where this research is happening
-
New York Blood Center
Rye, United States Active
Researchers
- Principal investigator: Shi, Patricia Ann — New York Blood Center
- Study coordinator: Shi, Patricia Ann
Related research
Other NIH-funded projects on the same topics.
-
How estrogen hormone therapy may change vaccine responses in adult transgender women
This study will look at how estrogen hormone therapy in adult transgender women affects their immune response to the seasonal COVID-19 vaccine.
-
Transfusion-driven hyperhemolysis in sickle cell disease
Aimed at understanding why some sickle cell patients have severe, dangerous reactions to blood transfusions and finding ways to prevent it.
-
How moving or traveling affects HIV prevention and care
This project looks at whether frequent moving or travel changes access to PrEP (HIV prevention) and HIV care for men who have sex with men in the U.S.
-
How bone marrow macrophages affect red blood cell production in polycythemia vera
This project looks at whether certain bone marrow immune cells and their signals cause too many red blood cells and if blocking those signals could help people with polycythemia vera.
-
Radiation protection that works differently for men and women
A study to understand why men and women react differently to radiation and to develop a new countermeasure that helps protect blood cells after radiation exposure.
-
Sickle cell bone marrow signals that drive platelet activation and red blood cell production
A patient-facing look at how sickle cell disease changes bone marrow to boost platelet activity and alter red blood cell formation, which may affect anemia and clotting.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.